Home > Insider Trading > Filing (0001140361-10-048998)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	AIS	Surgical & Medical Instruments & Apparatus (3841)	411350192

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187498	Dario Carrara	C/O Antares Pharma, Inc 250 Phillips Blvd, Suite 290 Ewing NJ 08618	Senior Vice President (1)	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-12-07	68,750	$0.85	96,250	No	4	M	Direct
Common Stock	Disposition	2010-12-07	68,750	$1.51	27,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2010-12-07	68,750	$0.00	68,750	$0.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
631,250		2019-05-13	No	4	M	Direct

Footnotes

Represents the exercise of stock options by Dario Carrara,Senior-Vice President of Antares Pharma, Inc., who resigned from his position effective December 31,2010, as disclosed in an 8-K filed September 16, 2010.
Dario Carrara received a grant of options on May 14, 2008, to purchase 82,500 shares of Common Stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vest in equal quarterly installments over three years.
Not applicable